In this study, we conducted a series of experiments to clarify that PLCG2, as an oncogene of CRC, significantly promoted CRC proliferation, invasion, metastasis, and EMT, regulated the cell cycle, and inhibited apoptosis. Here, PLCG2 is linked to colorectal carcinoma.